Evidence map›Paper›PMID 42745943›Full record

ReviewMolecular neurodegeneration advances2026

Autophagy-lysosomal pathway in neurodegeneration.

Samantha R McDonough, Aditya K Rao, Jacqueline M McAleer, Bergan M Babrowicz, Manu Sharma

Abstract readReview
In one paragraph

Review in Molecular neurodegeneration advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samantha R McDonough *Appel Institute for Alzheimer's Disease Research, and Feil Family Brain & Mind Research Institute, Weill Cornell Medicine, New York, NY USA.
Aditya K Rao *Appel Institute for Alzheimer's Disease Research, and Feil Family Brain & Mind Research Institute, Weill Cornell Medicine, New York, NY USA.
Jacqueline M McAleer *Appel Institute for Alzheimer's Disease Research, and Feil Family Brain & Mind Research Institute, Weill Cornell Medicine, New York, NY USA.
Bergan M Babrowicz *Appel Institute for Alzheimer's Disease Research, and Feil Family Brain & Mind Research Institute, Weill Cornell Medicine, New York, NY USA.
Manu SharmaAppel Institute for Alzheimer's Disease Research, and Feil Family Brain & Mind Research Institute, Weill Cornell Medicine, New York, NY USA.ORCID https://orcid.org/0000-0001-7394-2419

Funding

Tau proteostasis by chaperone-complexes in tauopathies including Alzheimer's diseaseR01AG083949 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Jacqueline Burre, Manu Sharma · 2024 to 2026
$2.1M
Mechanism and rescue of lysosomal defects in Adult-onset Neuronal Ceroid LipofuscinosisF31NS143430 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI MCDONOUGH, SAMANTHA R · 2025 to 2025
$50k
NIA NIH HHS R01 AG083949NINDS NIH HHS F31 NS143430
6 · The paper itself

Abstract

Autophagy-Lysosomal Pathway (ALP) dysfunction has emerged as a prominent mechanism underlying neurodegenerative disease. Given its central role in facilitating cellular clearance of misfolded proteins, damaged organelles and other cellular debris, the ALP is vital for cellular health and survival. In mature neurons, whose post-mitotic state renders them unable to dilute such materials through cell division, this waste removal pathway takes on an even greater importance. It is therefore unsurprising that ALP dysfunction is increasingly implicated in the context of age-associated neurodegenerative disease, where impaired proteostasis and pathological protein aggregation are common hallmarks. The focus of this review is how dysregulation of ALP-associated processes, including autophagic flux, chaperone-mediated autophagy, endolysosomal trafficking, lysosomal pH and ion balance, and lysosomal metabolic signaling, is implicated in both the pathogenesis and progression of neurodegenerative diseases, with an emphasis on Alzheimer's disease and Parkinson's disease. A more detailed understanding of how these processes, both independently and cooperatively, contribute to the development and progression of neurodegenerative disease will improve our understanding of these debilitating disorders and inform the development of ALP-targeted therapeutic strategies.

Indexed as

Alzheimer’s diseaseAutophagyLysosomeNeurodegenerationParkinson’s diseaseProteostasis

Identifiers

PMID42745943
PMCPMC13574747

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.